An open, single-arm design clinical trial on the treatment of hyperplasia of mammary gland by Yin and Yang double acupoint method

Beijing Jifangtang Academy of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. It meets the diagnostic criteria of western medicine for breast hyperplasia, and the course of disease is longer than 3 months;
•2. Breast color ultrasound BI-RADS classification 2-3;
•3. Aged over 18 years old;
•4. Average VAS score for pain>=4, monthly pain days >=3 days, and target mass still exists on palpation;
•5. Informed consent. Volunteers sign the informed consent.

•1. Women in pregnancy, lactation, menopause, severe menstrual cycle disorder or functional uterine bleeding;
•2. Taking contraceptives and sex hormone drugs;
•3. Patients with serious primary diseases of the heart, liver, kidney and hematopoietic system, or with mental illness;
•4, Allergic constitution or allergy to the ingredients of this product;
•5. Severe spinal injury, systemic skin disease, skin ulceration, cancer, life cycle less than three months, infectious diseases;
•6. Those who plan to become pregnant within 3 months;
•7. Alcoholics and/or psychoactive substances, drug abusers and dependents;
•8. Those who are using Chinese and Western medicines for breast hyperplasia within one month or now before this treatment (including medicine for external application, acupuncture, etc.) and have not used hormone drugs within half a year;
•9. Participated in other clinical trials within 3 months.

发起方

Beijing Jifangtang Academy of Traditional Chinese Medicine